Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycaemic control in children and adolescents with type 2 diabetes
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms Ellipse
- Sponsors Novo Nordisk
- 03 Aug 2017 Planned End Date changed from 29 Jun 2020 to 20 May 2020.
- 10 Jun 2017 Biomarkers information updated
- 03 Jun 2017 This trial is discontinued in the Greece.